By Joel Reese, WeSeed
The recession has hit almost everyone pretty hard.
Wait, scratch that — it’s hit almost every person hard. Dogs, cats, and other pets are doing quite well these days.
Americans will spend roughly $45.4 billion on their pets this year, estimates the American Pets Association. (That’s up $2.2 billion from last year, the group notes.)
And this goes beyond your dog’s Derm Care Anti-Bacterial Medicated shampoo ($14.99), or your cat’s argyle sweater ($35), or your dog’s hand-painted blue dress with strawberries ($59.95). We’re talking doggie spas, pet insurance, veterinary bills that make your elective appendectomy look cheap, and things like this German custom-built cat condo ($1,034).
Meanwhile, just for fun, we’ll note that luxury store Saks Fifth Avenue (SKS) posted a 15 percent sales loss compared to last year, which is pretty much the standard trend in retail.
So enough about that — which companies will profit from people’s peculiar pet preferences? To my mind, this brings to mind another axiom: If you want to strike it rich during a gold rush, invest in picks and shovels. The point: So who services pets?
The first company that comes to mind is PetSmart (PETM) — you’d think that stock would be shooting through the woof, right? At first, it seems the company is barking up the wrong tree. Even though the market’s dog days are starting to turn around, the stock has gone from $35 per share last year to about $21 per share today. (Ok, I’ll stop with the pet puns. It’s just so doggone tempting!)
But according to this Motley Fool story, PetSmart is actually doing pretty well: earnings were up 4.6 percent last quarter, and sales were up some 5 percent. So even though other companies are trying to creep into the pet market — Amazon (AMZN) and Target (TGT) come to mind — PetSmart is still a player here.
If PetSmart’s numbers frighten you, there are other companies taking advantage of this four-legged friend fervor. PetMed Express (PETS), which sells prescription drugs for Fido and friends, is at around $18, up from $11 a little over a year ago. The company’s ROC (return on capital, which is basically a way to tell how effectively a company is using its money) is a strong 31 percent over the last three years, and they tap into a potentially burgeoning market: The company can undersell vets via their 1-800-PETMEDS, who aren’t usually interested in passing along bargains to pet owners.
Then there’s Patterson Companies (PDCO), which makes veterinary supplies, is at $27 per share, up from below $17 just a few months ago. The Minnesota-based company has seen an increase in sales and gross operating profit over the last four years.
The lesson here: follow the crowds, and right now the crowds are making their pets happy. So maybe you should put your money where your leash is and let Fido guide your finances. Just a thought.
image by Tobyotter

![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=d0258570-0913-4b4b-9c77-dc23ed734451)



